Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Mar 16, 2021, after the close
10-K filed Mar 16, 2021, 75 days after period end · 0001564590-21-013589
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|
| Revenue | $4.47M | — |
| Net Income | -$19.03M | $42.17M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 16, 2021 · 75 d after period end
+5.1% from the close of Mar 12, 2021 to the close of Mar 17, 2021, the first after the release.